CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.52 HKD | +4.82% |
|
+11.26% | -10.19% |
| Apr. 24 | CSPC Pharmaceutical's EBT Buys 8.5 Million Shares | MT |
| Apr. 19 | CSPC Pharmaceutical Group Limited and CSPC Holdings Company Limited Enter into Master Sales Agreement | CI |
| Sales 2023 | 34.17B 4.36B | Sales 2024 * | 37.59B 4.8B | Capitalization | 73.65B 9.41B |
|---|---|---|---|---|---|
| Net income 2023 | 6.38B 815M | Net income 2024 * | 7.13B 910M | EV / Sales 2023 | 2.52 x |
| Net cash position 2023 * | 14.59B 1.86B | Net cash position 2024 * | 17.38B 2.22B | EV / Sales 2024 * | 1.5 x |
| P/E ratio 2023 |
13.5
x | P/E ratio 2024 * |
10.4
x | Employees | 23,500 |
| Yield 2023 * |
3.37% | Yield 2024 * |
3.07% | Free-Float | 70.21% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +4.66% | ||
| 1 week | +11.09% | ||
| Current month | +5.85% | ||
| 1 month | +2.68% | ||
| 3 months | +6.72% | ||
| 6 months | +8.86% | ||
| Current year | -10.33% |
1 week
5.65
6.55
1 month
5.656.55
Current year
5.567.37
1 year
5.208.25
3 years
5.2012.68
5 years
5.2012.68
10 years
2.7713.93
| Managers | Title | Age | Since |
|---|---|---|---|
Cui Long Zhang
CEO | Chief Executive Officer | 55 | 95-12-31 |
Dong Chen Cai
CHM | Chairman | 70 | 97-12-31 |
Hao Jiang
BRD | Director/Board Member | 41 | 20-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 70 | 97-12-31 |
Huai Yu Wang
BRD | Director/Board Member | 61 | 09-12-31 |
Kin Man Chak
BRD | Director/Board Member | 58 | 04-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.05% | 2 M€ | -19.10% | - | |
| 2.02% | 4 M€ | -27.92% | ||
| 1.07% | 3 M€ | -3.61% | - | |
| 0.99% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 6.52 | +4.82% | 67 812 245 |
| 24-04-24 | 6.22 | +2.81% | 40,605,810 |
| 24-04-23 | 6.05 | +0.83% | 31,703,370 |
| 24-04-22 | 6 | +3.99% | 42,020,550 |
| 24-04-19 | 5.77 | -1.54% | 60,339,850 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 03:34 am EDT
More quotes
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.22
HKD
Average target price
9.348
HKD
Spread / Average Target
+50.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.33% | 9.4B | |
| +25.61% | 660B | |
| +23.35% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +12.62% | 219B | |
| -9.86% | 196B | |
| +6.68% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 1093 Stock
